Accucaine Injection, Solution
FDA Recall NDC 76420-715

FDA Enforcement Report: View Recall Date, Reasons, and Safety Status

Active & Historical Enforcement Reports

The FDA has identified 1 recorded enforcement report(s) associated with Accucaine (NDC 76420-715). A significant event, classified as Class II, was initiated on Jun 08, 2026 by Asclemed Usa, Inc.. The reported reason for this action was: "Lack of Assurance of Sterility"

This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.

Reported Recall Events

June 2026 Class II Recall: Lack of Assurance of Sterility

Recall Number
Class II Ongoing
Reason for Recall
Lack of Assurance of Sterility
Initiated
Jun 08, 2026
Reported
Jul 08, 2026
Quantity
N/A

Recall Profile & Regulatory Data

Event ID
99204
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
Asclemed USA Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
USA Nationwide
Product Description
Accucaine, Kit contains: Lidocaine HCl Injection USP, 1% (10 mg/mL), 5 mL single dose ampule, Rx Only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-715-01.
Batch or Lot Expiration Information
Lot# : AE3102, 121924X2, 022525X4, 033125X1, 030426X2, 033125X2, 041725X3, 061225X1, 072225X3, 080525X6, 080525X7, 080525X8, 091225X1, 100225X2, 100625X1, 122225X4, 010626X3, 041326X4, Exp 11/30/2026; AE5052, 041426X2, 041726X1, 051826X2, Exp 04/30/2028.
Affected Packages Involved in this Recall
76420-715-01Product

About FDA Recall Enforcement Reports

FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.

If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.